Azapyridinomacrocycles Bearing Trialkanoic Acid Side Chains as Ligands for Lanthanide Ions
FULL PAPER
drous DMF (100 mL) at 100 °C under argon for 2 h. A solution
0:10, then MeOH/aq. NH3 (32%), 7:3]. The chromatographed
of 2,6-bis(bromomethyl)pyridine (1.31 g, 4.86 mmol) in anhydrous product was dissolved in CH2Cl2 (100 mL) and the cloudy solution
DMF (100 mL) was then added dropwise (during 5 h) and the mix-
ture was stirred for an additional 1 h. The crude mixture was con-
centrated and the residue was taken up in CH2Cl2 (250 mL). The
organic phase was washed with an aqueous solution of NaOH
(0.1 , 2 ϫ 70 mL) and was then dried with sodium sulfate and
concentrated.
was filtered. The filtrate was concentrated, yielding the title com-
pound 10a as a light brown oil (0.990 g, 2.81 mmol, 95%). 1H
NMR (400 MHz, CDCl3, 25 °C): δ ϭ 1.42 [s, 9 H, C(CH3)3], 1.74
3
[m, 4 H, N(CH2CH2CH2NH)2], 2.50 [t, JH,H ϭ 5.8 Hz, 4 H,
N(CH2CH2CH2NH)2], 2.55 [t, 3JH,H
ϭ
5.8 Hz,
4
H,
N(CH2CH2CH2NH)2], 3.14 (s, 2 H, NCH2CO2tBu), 3.88 (s, 4 H,
3
CPyrCH2NH), 6.98 (d, JH,H ϭ 7.6 Hz, 2 H, m-CHAr), 7.52 (dd,
tert-Butyl
{3,11-Bis(2-nitrobenzenesulfonyl)-3,7,11,17-tetraazabi-
3JH,H ϭ 3JH,HЈ ϭ 7.6 Hz, 1 H, p-CHAr) ppm. 13C NMR (100 MHz,
CDCl3, 25 °C): δ ϭ 27.0 [N(CH2CH2CH2NH)2], 28.2 [C(CH3)3],
46.3 [N(CH2CH2CH2NH)2], 52.0 [N(CH2CH2CH2NH)2], 54.3
(CPyrCH2NH), 55.3 (NCH2CO2tBu), 80.9 [C(CH3)3], 120.4 (m-
CHAr), 136.4 (p-CHAr), 159.1 (Cquat,Ar), 170.7 (CO2tBu) ppm. CI-
HRMS: m/z calcd. for C19H33N4O2 349.2604, found 349.2599
[M ϩ H]ϩ.
cyclo[11.3.1]heptadeca-1(17),13,15-trien-7-yl}acetate (14a): The title
compound was obtained from the sulfonamide 8a as a light brown,
amorphous solid (1.99 g, 2.77 mmol, 71%) after chromatography
1
on silica gel (n-heptane/EtOAc, 4:6 to 0:10). H NMR (400 MHz,
CDCl3, 25 °C):
N(CH2CH2CH2NNos)2], 2.39 [t, JH,H
δ ϭ 1.37Ϫ1.45 [m, 13 H, C(CH3)3 and
3
ϭ
6.7 Hz,
4
H,
N(CH2CH2CH2NNos)2], 3.00 (s, 2 H, NCH2CO2tBu), 3.30 [t,
3JH,H ϭ 7.6 Hz, 4 H, N(CH2CH2CH2NNos)2], 4.56 (s, 4 H,
tert-Butyl 3-{3,7,11,17-Tetraazabicyclo[11.3.1]heptadeca-1(17),13,
15-trien-7-yl}propionate (10b): After 5 h of stirring at room tem-
perature, the Na2CO3 was filtered off through a Celite pad and
washed with CH2Cl2. The filtrate was concentrated and the crude
product was purified by chromatography on neutral activated alu-
minium oxide (CH2Cl2/MeOH, 10:0 to 8:2) to yield the title com-
3
C
PyrCH2NNos), 7.45 [d, JH,H ϭ 7.7 Hz, 2 H, m-CHAr (Pyr)],
7.62Ϫ7.73 [m, 7 H, CHAr (Nos) and p-CHAr (Pyr)], 8.00Ϫ8.03 [m,
2 H, CHAr (Nos)] ppm. 13C NMR (100 MHz, CDCl3, 25 °C): δ ϭ
26.7
[N(CH2CH2CH2NNos)2],
28.2
[C(CH3)3],
47.0
[N(CH2CH2CH2NNos)2], 51.2 [N(CH2CH2CH2NNos)2], 54.2
(CPyrCH2NNos), 57.8 (NCH2CO2tBu), 80.9 [C(CH3)3], 123.2 [m-
CHAr (Pyr)], 124.2, 130.6, 131.8 [CHAr (Nos)], 133.1 [Cquat,Ar
(Nos)], 133.6 [CHAr (Nos)], 138.3 [p-CHAr (Pyr)], 148.1 [Cquat,Ar
(Nos)], 155.9 [Cquat,Ar (Pyr)], 170.6 (CO2tBu) ppm. CI-HRMS: m/
z calcd. for C31H39N6O10S2 719.2169, found 719.2171 [M ϩ H]ϩ.
1
pound 10b as an orange oil (0.901 g, 2.48 mmol, 84%). H NMR
(400 MHz, CDCl3, 25 °C): δ ϭ 1.32 [s, 9 H, C(CH3)3], 1.73 [m, 4
3
H, N(CH2CH2CH2NH)2], 2.24 (t, JH,H
ϭ
7.2 Hz,
2
H,
H,
H,
H,
ϭ
NCH2CH2CO2tBu), 2.41 [t, 3JH,H
N(CH2CH2CH2NH)2], 2.53 [t, 3JH,H
N(CH2CH2CH2NH)2], 2.65 (t, 3JH,H
ϭ
5.7 Hz, 4
ϭ
ϭ
6.2 Hz,
7.2 Hz,
4
2
3
tert-Butyl 3-{3,11-Bis(2-nitrobenzenesulfonyl)-3,7,11,17-tetraazabi-
cyclo[11.3.1]heptadeca-1(17),13,15-trien-7-yl}propionate (14b): The
title compound was obtained from sulfonamide 8b as a light orange
oil (1.46 g, 1.99 mmol, 51%) after chromatography on silica gel (n-
NCH2CH2CO2tBu), 3.90 (s, 4 H, CPyrCH2NH), 6.99 (d, JH,H
3
3
7.6 Hz, 2 H, m-CHAr), 7.53 (dd, JH,H ϭ JH,HЈ ϭ 7.6 Hz, 1 H, p-
CHAr) ppm. 13C NMR (100 MHz, CDCl3, 25 °C): δ ϭ 27.2
[N(CH2CH2CH2NH)2], 28.0 [C(CH3)3], 31.5 (NCH2CH2CO2tBu),
46.1 [N(CH2CH2CH2NH)2], 47.7 (NCH2CH2CO2tBu), 51.4
[N(CH2CH2CH2NH)2], 53.9 (CPyrCH2NH), 80.2 [C(CH3)3], 120.7
(m-CHAr), 136.7 (p-CHAr), 158.6 (Cquat,Ar), 172.1 (CO2tBu) ppm.
CI-HRMS: m/z calcd. for C20H35N4O2 363.2760, found 363.2757
[M ϩ H]ϩ.
1
heptane/EtOAc, 4:6 to 0:10). H NMR (400 MHz, CDCl3, 25 °C):
δ ϭ 1.31 [s, 9 H, C(CH3)3], 1.39 [m, 4 H, N(CH2CH2CH2NNos)2],
2.13Ϫ2.17 [m, 6 H, N(CH2CH2CH2NNos)2(CH2CH2CO2tBu) or
3
N(CH2CH2CH2NNos)2(CH2CH2CO2tBu)], 2.48 (t, JH,H
ϭ
3
6.8 Hz, 2 H, NCH2CH2CO2tBu), 3.26 [t, JH,H ϭ 7.4 Hz, 4 H,
N(CH2CH2CH2NNos)2 or N(CH2CH2CH2NNos)2], 4.54 (s, 4 H,
CPyrCH2NNos), 7.43 [d, JH,H ϭ 7.7 Hz, 2 H, m-CHAr (Pyr)],
3
5. N-Alkylations of Macrocyclic Intermediates
7.62Ϫ7.73 [m, 7 H, CHAr (Nos) and p-CHAr (Pyr)], 8.00Ϫ8.02 [m,
tert-Butyl {3,11-Bis(tert-butoxycarbonylmethyl)-3,7,11,17-tetraaza-
bicyclo[11.3.1]heptadeca-1(17),13,15-trien-7-yl}acetate (4a): tert-Bu-
tyl bromoacetate (2.3 mL, 15.58 mmol, 12 equiv.) was added to a
suspension of compound 3 (0.301 g, 1.28 mmol) and Ag2CO3
(0.899 g, 3.26 mmol, 2.5 equiv.) in anhydrous THF (10 mL). After
1 h of stirring at room temperature, the reaction mixture was co-
oled and acidified to pH ϭ 1 with an aqueous solution of HCl (ca.
6 , 2.5 mL, ca. 15 mmol). The mixture was stirred at 0 °C for
an additional 0.5 h, and Na2S·9H2O (10.6 g, 44.1 mmol) was then
added. After dilution with H2O (5 mL), the basic suspension was
stirred for 3 h and was then warmed to room temperature. The
black solid was filtered through a Celite pad and was then washed
with CH2Cl2. The filtrate was concentrated and the resulting aque-
ous phase was extracted with CH2Cl2 (5 ϫ 40 mL). The organic
phase was dried (Na2SO4) and concentrated to give a crude orange
oil that was purified by chromatography on neutral activated alu-
minium oxide (n-heptane/EtOAc, 7:3 to 5:5) to give the title com-
pound 4a as a yellow oil (0.603 g, 1.04 mmol, 81%). 1H NMR
(400 MHz, CDCl3, 25 °C): δ ϭ 1.34 [s, 9 H, N(CH2CH2CH2-
2 H, CHAr (Nos)] ppm. 13C NMR (100 MHz, CDCl3, 25 °C): δ ϭ
26.2
[N(CH2CH2CH2NNos)2],
28.1
[C(CH3)3],
33.8
(NCH2CH2CO2tBu), 47.3, 50.7 [N(CH2CH2CH2NNos)2], 51.1
(NCH2CH2CO2tBu), 54.4 (CPyrCH2NNos), 80.2 [C(CH3)3], 123.1
[m-CHAr (Pyr)], 124.2, 130.6, 131.8 [CHAr (Nos)], 133.0 [Cquat,Ar
(Nos)], 133.7 [CHAr (Nos)], 138.2 [p-CHAr (Pyr)], 148.1 [Cquat,Ar
(Nos)], 156.0 [Cquat,Ar (Pyr)], 171.8 (CO2tBu) ppm. CI-HRMS: m/
z calcd. for C32H41N6O10S2 733.2326, found 733.2326 [M ϩ H]ϩ.
4. General Procedure for the Cleavage of Sulfonamide Subunits from
Functionalised Macrocycles 14a and 14b: In a typical procedure, a
solution of macrocycle 14a or 14b (2.96 mmol) in anhydrous DMF
(200 mL) was cannulated into a three-necked flask containing an-
hydrous Na2CO3 (3.20 g, 30.22 mmol). Thiophenol (1 mL,
9.74 mmol) was then added.
tert-Butyl {3,7,11,17-Tetraazabicyclo[11.3.1]heptadeca-1(17),13,15-
trien-7-yl}acetate (10a): After stirring overnight at room tempera-
ture, the reaction mixture was concentrated and then taken up in
CH2Cl2 (200 mL). The organic layer was washed with water (100 NCH2CO2tBu)2{CH2CO2C(CH3)3}], 1.39Ϫ1.44 [m, 22 H,
mL). The aqueous layer was further extracted with CH2Cl2 (3 ϫ
100 mL). The combined organic layers were dried (Na2SO4) and
then concentrated under reduced pressure. The crude product was
purified by chromatography on silica gel [CH2Cl2/MeOH, 10:0 to
N{CH2CH2CH2NCH2CO2C(CH3)3}2], 2.45 [broad t,
4
H,
N(CH2CH2CH2NCH2CO2tBu)2 or N(CH2CH2CH2NCH2CO2t-
Bu)2], 2.55 [t, 3JH,H ϭ 7.3 Hz, 4 H, N(CH2CH2CH2NCH2CO2tBu)2
or N(CH2CH2CH2NCH2CO2tBu)2], 2.92 [s,
2
H, N(CH2-
Eur. J. Org. Chem. 2004, 4424Ϫ4436
2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 4433